AcousticaBio, Inc
AcousticaBio, Inc., a preclinical biotechnology company spun out from Harvard in 2022, is dedicated to addressing significant challenges in the delivery of novel therapeutics through its proprietary fluid processing technology. Backed by venture funding and the NIH, the company has established collaborations with leading global biopharmaceutical firms, demonstrating strong in vitro and in vivo safety and efficacy data.
Led by a team of innovative experts, including founder and CEO Daniele Foresti, AcousticaBio is committed to building a better future in life sciences. The company's scientific co-founder, Professor Jennifer Lewis, along with a diverse team of engineers and operations professionals, drives its mission forward.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.